infections. The effects of virus persistence on innate immunity, including NK cell responses, and the underlying mechanisms are not fully understood. We examined the frequency, phenotype, and function of peripheral blood CD3 ؊ CD56 ؉ NK subsets in HIV ؉ and HCV ؉ patients and identified significantly reduced numbers of total NK cells and a striking shift in NK subsets, with a marked decrease in the CD56 dim cell fraction compared to CD56 bright cells, in both infections. This shift influenced the phenotype and functional capacity (gamma interferon production, killing) of the total NK pool. In addition, abnormalities in the functional capacity of the CD56 dim NK subset were observed in HIV ؉ patients. The shared NK alterations were found to be associated with a significant reduction in serum levels of the innate cytokine interleukin 15 (IL-15). In vitro stimulation with IL-15 rescued NK cells of HIV ؉ and HCV ؉ patients from apoptosis and enhanced proliferation and functional activity. We hypothesize that the reduced levels of IL-15 present in the serum during HIV and HCV infections might impact NK cell homeostasis, contributing to the common alterations of the NK pool observed in these unrelated infections.
Persistent viral infections constitute a major health burden worldwide. Human immunodeficiency virus type 1 (HIV-1) causes a persistent infection in humans that is ultimately associated with the development of AIDS. Around 40 million people are infected with this virus worldwide, with approximately 3 million deaths occurring per year due to AIDS (73) . Hepatitis C virus (HCV) affects more than 170 million people and causes an estimated 460,000 deaths per year (24) . A small proportion of patients are able to clear this infection, but most become carriers and may eventually develop chronic liver diseases, including chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. There is a pressing need to develop both prophylactic vaccines and effective therapeutic strategies for these infections. To facilitate this, a better understanding of mechanisms involved in the initiation and maintenance of persistence and of alterations in host immune function induced in the context of viral persistence is urgently required.
The importance of adaptive immune responses in combating virus infections is well known. Much work has focused on the roles played by humoral and T-cell responses in control of HIV and HCV infections, and a variety of immune evasion strategies have been identified (42, 44, 57, 66) . By contrast, innate immune responses remain relatively poorly characterized (11, 47, 50, 70) . It is increasingly recognized that optimal control of persistent infections requires interaction between multiple arms of the immune response (48) . Innate immune responses play an important role in early effector functions and in the activation and maintenance of adaptive immune responses (13, 28) and also participate in containment of persistent viral infections (34) . Defects in innate responses may thus impact directly or indirectly on the control of viral replication and are, therefore, important to characterize.
NK cells contribute to innate host defense by cytolysis and production of cytokines such as gamma interferon (IFN-␥). CD56 ϩ CD3 Ϫ NK cells constitute ϳ13% of human peripheral blood mononuclear cells. Two subpopulations of NK cells expressing different levels of CD56 have been described. Most NK cells (90%) are CD56 dim . These cells are the main mediators of NK cytotoxicity, contain high levels of perforin, and express CD16 (Fc␥RIII) (21) . The CD56 dim subset expresses a unique repertoire of natural killer receptors distinct from those found on CD56 bright NK cells (21) . A minority of NK cells (10%) are CD56 bright . They exert only weak cytotoxic activity but act as an important source of immunoregulatory cytokines (21) . Interleukin 12 (IL-12) and IL-18 have been shown to be strong inducers of NK cell production of IFN-␥ (19) .
NK cell development and maturation are strongly influenced by the innate cytokine IL-15 (49, 51, 77, 79) . IL-15 is produced by multiple cell types, including fibroblasts, epithelial cells, and stromal cells. It is also produced by mature dendritic cells (DCs) in response to IFN-␣/␤ and danger signals, such as double-stranded RNA or lipopolysaccharide, and promotes DC activation in an autocrine manner (55) . IL-15 is involved in the activation and homeostatic maintenance of cells of both the innate and adaptive immune systems. It plays an important role in CD8 T-cell homeostasis by promoting survival or proliferation of naive and memory phenotype CD8 T cells (5, 10, 36, 76, 80) and influences NK survival (27, 58) . The defects observed in NK and memory T-cell lineages in IL-15-deficient mice attest to the obligatory role played by this cytokine in their generation and survival (46, 68, 78) .
In this study, we addressed the frequency, phenotype, and functional capacity of CD56 ϩ CD3 Ϫ NK cells and the subsets, CD56 dim and CD56 bright , in HIV ϩ and HCV ϩ patients. In both infections we found a reduced frequency of NK cells and an altered subset distribution, which affected the functional capacity of the total NK pool. Given the involvement of IL-15 in NK cell homeostasis, we then addressed whether there were changes in serum levels of IL-15 and observed a significant reduction in serum IL-15 levels of both HIV ϩ and HCV ϩ patients. We show that IL-15 rescued NK cells of HIV ϩ and HCV ϩ patients from apoptosis and promoted proliferation and NK cell function. Reduced serum levels of IL-15 may constitute a common mechanism underlying the NK cell abnormalities in these two unrelated chronic virus infections.
MATERIALS AND METHODS

Patients. HIV
ϩ and HCV ϩ patients were recruited from the Mortimer Market Centre, London, United Kingdom, the Institute of Hepatology, University College London, United Kingdom, and the Gastroenterology clinic at the John Radcliffe Hospital, Oxford, United Kingdom. Ethical approval was obtained from local institutional review boards, and blood was drawn following written informed consent. HCV ϩ patients were consistently HCV RNA ϩ and had median alanine aminotransferase levels of 80 IU (range, 17 to 187); none of these individuals were currently or recently (within the last 6 months) on IFN-␣ treatment. HIV ϩ patients were not receiving antiretroviral therapy and were all clinically asymptomatic, with median CD4 counts of 480 cells/mm 3 (range, 260 to 1,130) and median viral loads of 28,800 RNA copies/ml (range, 1,900 to 275,600). None of the patients included in this study were coinfected with HIV and HCV. The controls were healthy age-matched HIV Ϫ , HCV Ϫ individuals. Phenotypic and functional studies. For direct phenotypic studies, CD3/56 staining was combined with CD57-fluorescent isothiocyanate (FITC) (BD/ Pharmingen, Oxford, United Kingdom). Intracellular perforin and Ki67 staining was performed with CD3/56 and perforin-FITC or Ki67-FITC (BD/Pharmingen) or a negative control antibody. Annexin V staining was done using Annexin V-FITC (BD/Pharmingen). To determine the capacity of NK cells to produce IFN-␥, frozen peripheral blood mononuclear cells (PBMC) (HIV ϩ patients) or whole blood (HCV ϩ patients) were incubated overnight with IL-12 (R&D Systems, Minneapolis, Minn.) and IL-18 (MBL, Nagoya, Japan) (each at 1.25 g/ ml). GolgiStop (BD/Pharmingen) was added for 3 h and cells permeabilized before staining with IFN-␥-FITC (BD/Pharmingen), CD56-PC5 (Coulter/Immunotech, Marseille, France), and CD3-phycoerythrin (BD/Pharmingen) or an immunoglobulin G control antibody (BD/Pharmingen). IFN-␥ production was compared to that of matched frozen or fresh cells from control individuals. All samples were acquired with a FACSCalibur (Becton Dickinson, Oxford, United Kingdom) and analyzed using CellQuest software (Becton Dickinson).
Preparation of LIL. Liver-infiltrating lymphocytes (LIL) were isolated from a surplus part of a liver biopsy specimen, which was obtained as part of a routine diagnostic procedure for HCV ϩ patients. The liver tissue was dissociated and the cell suspension passed through a nylon mesh (Becton Dickinson Labware, Oxford, United Kingdom) and centrifuged to pellet the hepatocytes. The supernatant was centrifuged to pellet the LIL. The yield of LIL from each specimen was 3 ϫ 10 5 to 5 ϫ 10 5 , with viability of Ͼ95%. Both we and others have previously shown that LIL isolated in this way are a distinct population of cells, with a higher frequency of virus-specific T cells than PBMC (1, 2, 38, 39 ). PBMC were obtained from each patient at the time of liver biopsy. Paired samples of LIL and PBMC from HCV ϩ patients were cryopreserved and stored in liquid nitrogen. Chromium release assay. NK cell cytolytic activity was assessed in a chromium release assay. K562 target cells (10 6 ) were labeled with 100 Ci of Na 51 CrO 4 (Amersham Pharmacia Biotech Ltd., Little Chalfont, United Kingdom) for 1 h at 37°C. Effector cells were frozen PBMC which had been incubated overnight with or without IL-15 (1 ng/ml) (R&D Systems, Minneapolis, Minn.) and used as effectors at different effector/target (E:T) ratios. The supernatant was harvested after a 5-h incubation at 37°C. The percent lysis was calculated as (mean test counts Ϫ mean spontaneous counts)/(mean maximum counts Ϫ mean spontaneous counts) ϫ 100.
CD107 (lysosome-associated membrane protein 1) expression assay. CD107a expression was used to measure NK cell degranulation, as recently described (4, 12) . PBMC were stimulated with or without IL-15 (1 ng/ml) overnight and then incubated with K562 target cells at E:T ratio of 5:1. CD107a-FITC antibody (BD Biosciences) was added directly to the cultures. Following 1 h of stimulation with K562 cells, GolgiStop was added for another 5 h at 37°C, and cells were then stained with CD56/3 antibody prior to fluorescence-activated cell sorting analysis.
IL-15 assay. Serum IL-15 concentrations were determined using the QuantiGlo chemiluminescence immunoassay (R&D Systems, Minneapolis, Minn. Statistical analysis. Analysis was performed using an unpaired t test, using Prism software (version 3.03; GraphPad Software Inc., San Diego, Calif.). 1b) . As a result, the CD56 bright /CD56 dim NK cell ratio was significantly altered for HIV ϩ and HCV ϩ patients relative to that for controls (controls, 0.06 Ϯ 0.02; HIV ϩ , 0.12Ϯ 0.02; P ϭ 0.04; HCV ϩ , 0.15 Ϯ 0.02; P ϭ 0.0034). This analysis thus identified that a significant decrease in NK cells and a significant shift of NK subsets had occurred during HIV and HCV infection.
RESULTS
Reduced frequencies of NK cells in HIV and
Decreased number of peripheral NK cells in HCV ؉ patients is not due to accumulation in liver. To address whether the altered subset composition of NK cells in the blood of HCV ϩ patients was due to selective accumulation of the CD56 dim NK cells in the liver, five pairs of LIL and matched PBMC from HCV ϩ patients were stained for CD56/CD3. As shown in Fig. 1c , we found similar ratios of NK subsets in the liver and blood. Hence, the reduced proportion of CD56 dim NK cells in the blood of HCV ϩ individuals was not due to their preferential accumulation in the liver.
Reduced IFN-␥ production by NK cells from HIV
؉ patients but not HCV ؉ patients following stimulation with IL-12 plus IL-18. To gain insight into the functional capacity of NK cells in HIV ϩ and HCV ϩ patients, we assessed their ability to produce IFN-␥, a cytokine that promotes the induction of adaptive immune responses (14, 67) and plays a key role in control of hepatotropic viruses (41) . We compared IFN-␥ production by CD56 bright and CD56 dim NK cells from HIV ϩ , HCV ϩ , and control individuals following stimulation with IL-12 plus IL-18 ( Fig. 2) . This stimulus elicited IFN-␥ production from around 25% of the NK cells (CD56 ϩ CD3 Ϫ ) of healthy control individuals. IFN-␥ was produced by both NK subsets, although the numerical superiority of the CD56 dim NK cells meant that they comprised the majority of the IFN-␥-producing cells in the total NK pool (CD56 dim IFN␥ ϩ , 92% A similar phenomenon was observed for HIV ϩ patients, where 36.3% of total IFN-␥-producing NK cells were derived from the CD56 bright subset (Fig. 2b) . Notably, however, there was also a reduction in the total number of NK cells induced to produce IFN-␥ upon stimulation with IL-12 plus IL-18 compared to results for control individuals (controls, 27.11% Ϯ 6.4%; HIV, 9.3% Ϯ 2.0%; P ϭ 0.026). (Fig. 3b) , resulting in a lower level of perforin expression in the total NK pool. In line with this, the cytotoxic capacity of the overall NK pool was decreased in both HCV ϩ patients and HIV ϩ patients (Fig. 3c) .
Greater replicative senescence of the CD56 dim subset, which is underrepresented in HIV ؉ and HCV ؉ individuals. The impact of the shift of NK cell subsets in HIV ϩ and HCV ϩ patients on the properties of the overall NK cell pool was also apparent when we examined expression of CD57, a marker associated with NK cell replicative senescence (16) . CD57 expression was exclusively observed on the CD56 dim subset in control, HIV ϩ , and HCV ϩ individuals (Fig. 4a) . Although the proportion of CD56 dim NK cells expressing CD57 was not significantly different for HIV ϩ , HCV ϩ , and control individuals, the percentage of all NK cells expressing CD57 was reduced in HIV ϩ and HCV ϩ patients with an altered subset ratio (data not shown). The staining pattern for CD57 was in concordance with ex vivo staining for Annexin V, a marker for apoptosis. As illustrated by the example in Fig. 4b, CD56 bright cells (in this case derived from a control individual) are negative for Annexin V and CD57, whereas the CD56 dim population is more prone to spontaneous apoptosis ex vivo (9) . After 1 week of culture, it was also predominantly the CD56 dim population of NK cells from control, HIV ϩ , and HCV ϩ individuals that underwent apoptosis (Fig. 4c) . Hence, the more senescent CD56
dim NK subset has a higher susceptibility to apoptosis than the CD56 bright subset. In summary, we saw decreased frequencies of NK cells in HCV ϩ and HIV ϩ patients and an altered subset distribution, which affected the phenotype and the functional capacity of the overall NK pool. In both infections we also found an accumulation of "early" NK forms (perforin low CD57 Ϫ ) and a decrease in "mature" forms (perforin high CD57 ϩ ), as has been reported for CD8 ϩ T cells in HIV ϩ and HCV ϩ patients (7, 40 Reduced serum levels of IL-15 in patients with HCV and HIV infection. The observation of common alterations in NK numbers, subset composition, and maturation state in both HIV and HCV infections raised the question of whether the underlying mechanisms may be similar in the two infections. We focused our attention on the innate cytokine IL-15, which is known to play an important role in lymphocyte homeostasis. We thus went on to address whether serum IL-15 levels were altered during HIV and HCV infection. A sensitive luciferasebased enzyme-linked immunosorbent assay was used to measure serum levels of IL-15. We found significantly reduced levels of IL-15 in the sera of HCV ϩ and HIV ϩ patients (Fig.  5a ) compared to those of healthy controls (controls, 3.3 pg/ml Ϯ 0.31; n ϭ 8; HIV ϩ , 1.88 pg/ml Ϯ 0.3; P ϭ 0.0056; n ϭ 10; HCV ϩ , 2.4 pg/ml Ϯ 0.23; P ϭ 0.036; n ϭ 11 (Fig. 5b) . To test the effect of IL-15 on NK cell survival, we isolated NK cells from a control individual by sorting and cultured them in medium containing picomolar concentrations of IL-15 (3 pg/ml; 30 pg/ml; 300 pg/ml). After 1 week of culture, the cells were stained with Annexin V to identify apoptotic cells. The proportion of Annexin V Ϫ NK cells increased as the cells were cultured with increasing concentrations of IL-15, indicating a direct effect of this cytokine on NK cell survival (Fig. 5c) .
We then addressed the ex vivo survival of NK cells from HIV ϩ and HCV ϩ patients in the presence or absence of IL-15. Cells from both patient groups remained responsive to IL-15, with a higher percentage of Annexin V Ϫ cells being observed after culture with IL-15 than in its absence (Fig. 5d) (Fig. 5f) .
IL-15 increases IFN-␥ production by NK cells from HIV
؉ and HCV ؉ patients and normal controls. Since we had shown that NK cells from patients responded normally to IL-15 with respect to proliferation and survival, we wanted to see whether they also responded normally to IL-15 with respect to increase in function. Fresh PBMC from HIV ϩ , HCV ϩ , and control individuals were stimulated overnight with IL-15 either alone or in combination with IL-12 plus IL-18. IL-15 alone (3 pg/ml, 1 ng/ml, and 10 ng/ml) did not lead to IFN-␥ production by NK 
IL-15 increases target cell-stimulated degranulation of NK cells from normal controls and HCV
؉ and HIV ؉ patients. Finally, we tested whether IL-15 could increase the cytolytic capacity of NK cells. Frozen PBMC were cultured with or without 1 ng/ml of IL-15 overnight, and their ability to degranulate following exposure to the major histocompatibility complex class I low K562 target cell line was assessed by the analysis of expression of CD107a, a marker expressed on the cell surface following activation-induced granule release. As recently described for both NK cells (3) uals ranged from 0 to 2.5% (mean of 1.2%). The percentage of CD56 dim NK cells expressing CD107a increased following incubation of PBMC with K562 cells (Fig. 7) ; notably, the percentage of NK cells within the CD56 dim pool induced to express CD107a following exposure to target cells did not differ for control, HIV ϩ , or HCV ϩ individuals (control, 15.5% Ϯ 3.7%; HIV ϩ , 17.06% Ϯ 2.9%; HCV ϩ , 14.73% Ϯ 1.8%), indicating that at least this aspect of NK cell function was not impaired in the patient groups. Overnight incubation with IL-15 dramatically enhanced target cell-stimulated degranulation of NK cells from both control and patient groups (control, 45.3% Ϯ 5.6%; HIV ϩ , 44.61% Ϯ 4.7%; HCV ϩ , 32.1% Ϯ 3.6%). Hence, NK cells from HIV ϩ and HCV ϩ patients stayed responsive to the effects of IL-15 on their functional capacity in addition to proliferation and survival.
DISCUSSION
Analysis of the frequency and function of CD56
ϩ CD3 Ϫ NK cells for HIV ϩ and HCV ϩ patients revealed a significant reduction in NK cell frequency and a quantitative imbalance of the CD56 bright and CD56 dim subsets within the total NK population. Since the two NK cell subsets exhibit different functional profiles, this perturbation resulted in alterations in the functional capacity of the overall NK pool in both infections. We addressed whether altered levels of the innate cytokine IL-15 could be contributing to the common changes in NK cell numbers and subset composition in these infections and found reduced levels of IL-15 in the serum of HIV ϩ and HCV ϩ patients. We show that IL-15 was able to increase the survival of NK cells from control, HIV ϩ , and HCV ϩ patients and promoted proliferation and effector functions. The augmenting effect of IL-15 on NK cell survival and functions supports its use as a therapeutic agent in HIV infection, where trials in animal models are already under way (61) , and suggests investigation of its use in HCV infection.
We analyzed in detail how the reduction in NK cell numbers and shift of NK subsets may lead to functional deficits within the total NK cell population of HIV ϩ and HCV ϩ patients. We first looked at the ability of NK cells to produce the cytokine IFN-␥, which has direct antiviral effects and may also affect the downstream adaptive immune response, e.g., promoting a shift of the T-cell functional phenotype towards Th1. We found that the ability of NK cells from HCV ϩ patients to make IFN-␥ in response to stimulation with IL-12 plus IL-18 was not impaired, although the overall reduction in NK cell numbers that occurs in the context of this infection may result in limited availability of NK cell-derived IFN-␥ in vivo. In HIV ϩ patients, there was also an additional impairment in the IFN-␥ production capacity of the CD56 dim NK subset, resulting in a significant reduction in IFN-␥ production by the total NK cell pool, as has also been observed in previous studies (56, 69) . Superimposed on the alteration in the NK cell subset composition, there thus also appear to be further abnormalities in NK cell functions in HIV ϩ individuals. Second, we looked at the differential perforin expression of the CD56 bright and CD56 dim subsets. The CD56 dim subset acts as the main cytolytic subset and expresses high levels of perforin and natural cytotoxicity receptors (21) . In HIV ϩ and HCV ϩ patients, there was a reduction in the lytic capacity of the overall NK pool, which correlated well with the proportional reduction of the CD56 dim NK subset. Degranulation of CD56 dim NK cells, a prerequisite for cytolytic activity, seemed functional in HIV ϩ and HCV ϩ patients, consistent with the hypothesis that the observed reduction in cytolytic activity of the total NK population in HIV ϩ and HCV ϩ patients may be due in large part to the proportional reduction in the CD56 dim cytolytic NK cell subset. Some previous studies have also reported a decrease in NK lytic activity in HCV and HIV infection (18, 23, 52, 72) , although others have not seen this (4, 26) .
The fact that we identified common alterations in the size and subset composition of the peripheral NK cell pool for patients chronically infected with two unrelated viruses, HIV and HCV, suggested that there may be a common underlying mechanism. Interestingly, similar observations have also been described for patients with postviral fatigue syndrome (60) , raising the possibility that this phenomenon may be characteristic of multiple chronic infections.
One potential explanation for the observed changes could be alterations in the tissue localization of NK subsets due to their selective trapping in the liver in the case of HCV infection or in the lymph nodes in HIV infection (a mechanism suggested to contribute to the reduction in peripheral CD4 ϩ T-cell numbers in HIV infection (17) . However, several lines of evidence argue against this. First, previous studies have shown that during HCV ϩ infection, the total number of NK cells in the liver is normal (25) or decreased (15, 45) . Second, we found that the ratios of the CD56 bright and CD56 dim subsets in the blood and liver of HCV ϩ patients were very similar. There is thus no evidence to support accumulation of NK cells or selective trapping of CD56 dim NK cells in the liver during chronic HCV infection. Accumulation of CD56 dim NK cells within the lymph nodes also seems unlikely, based on what is known about their trafficking pattern. It is the CD56 bright NK subset, which expresses CCR7 and high levels of L-selectin, that has been found to be present in lymph nodes (29, 74) .
Instead, we favor the hypothesis that there may be alterations in NK cell homeostasis in HIV and HCV infection, resulting in a reduction in overall NK cell numbers and a widespread imbalance between the two NK subsets. The NK cell subset ratio could be altered by enhanced production, expansion, or survival of the CD56 bright pool, accompanied by decreased generation or survival of CD56 dim NK cells. Alternatively, if there were a lineage relationship between these two NK cell subsets (which has been suggested on the basis that CD56 dim NK cells appear to be more terminally differentiated than the CD56 bright population (21) , the balance between these two pools could be altered by impaired maturation of CD56 bright cells into CD56 dim cells. Biasing of the NK pool in chronic infection towards a potentially less-mature cell subset would have interesting parallels to the enrichment of virusspecific CD8 T cells with an "immature" phenotype (CD27 ϩ
CD28
ϩ perforin low ) in HIV and HCV infection (7, 8, 40) . However, recent evidence suggests that both subsets are in fact products of distinct differentiation lineages (35) , making the former hypothesis more likely.
Given the possibility that there may be abnormalities in NK cell homeostasis in HIV ϩ and HCV ϩ infections, we addressed whether a deficit in the innate cytokine IL-15 might be partly responsible. IL-15 is known to play an important role in the homeostatic proliferation of naive and memory CD8 T cells (10, 80) . Likewise, it is also thought to regulate the homeostasis and functional capacity of NK cells (75) and has been shown to promote NK survival ex vivo (20) . We observed that serum levels of IL-15 were reduced during HIV and HCV infections, suggesting that abnormalities in the production of this cytokine may have contributed to the reduction in NK cell numbers and the decrease in the CD56 dim population in these infections. Serum IL-15 levels were reduced more dramatically for HIV ϩ than for HCV ϩ individuals, and the reduction in overall NK cell numbers was also much greater in the former infection, as would be expected if the two observations were related.
Notably, we found that although the survival of both NK cell subsets was promoted by IL-15 in vitro, the CD56 dim NK subset had a greater tendency to undergo apoptosis in the absence of IL-15, and this cytokine had a much more prominent effect on CD56 dim cell survival than that of CD56 bright NK cells. If IL-15 deficiency also has a greater impact on CD56 dim than CD56 bright NK cell survival in vivo, this could result in an increase in the CD56 bright /CD56 dim cell ratio within the peripheral blood NK cell population. Consistent with this, we observed an increase in the CD56 bright /CD56 dim NK cell subset ratio in the context of reduced serum IL-15 levels in HIV ϩ and HCV ϩ individuals. However, the effects seen might not be solely dependent on IL-15; other factors may also be important in determining the phenotype and function of NK cells in these infectious settings. One potential candidate is the recently described cytokine IL-21, which acts in synergy with IL-15 (64) .
Given that pathogen components are among the stimuli that elicit production of IL-15, it might have been expected that there would be elevated levels of IL-15 in the serum of patients harboring chronic viral infections. The observed reduction in serum levels might reflect the existence of intrinsic mechanisms for down-regulation of innate responses in the face of chronic stimulation, to reduce associated immunopathological damage. Alternatively, chronic infection might have led to impairment in the number, functional capacity, or responsiveness of IL-15-producing cells. Mature DC constitute one important cellular source of IL-15. A complex cross talk between DC and NK cells has been proposed (22, 31, 37, 59) , whereby DC control functional properties of NK cells and NK cells control DC (30, 32, 65) . IFN-␣ is an important stimulus for the induction of IL-15 production by DCs (63) . It is notable that in HIV infection, there is a reduction in the number of plasmacytoid DCs (which produce high levels of IFN-␣/␤) in the peripheral blood (71) . Although in HCV infection, pDC numbers are not dramatically reduced, their IFN-␣ production capacity may be impaired (6, 62) . A recent study also suggested that there may be abnormalities in the ability of DCs from HCV ϩ patients to produce IL-15 in response to IFN-␣ stimulation (43) .
IL-15 is currently proposed as adjuvant immunotherapy for HIV ϩ individuals (18, 53, 54) and has also been shown to curtail infections by human herpesviruses (33) . Our data indicate that it may also be beneficial in HCV infection, where IFN-␣ treatment is already used, and may potentially be useful in other chronic infections too. A better understanding of the precise nature of the deficits in the innate immune system in chronic infections will be important for the design of appropriate therapeutic strategies.
